Literature DB >> 12913343

Prenatal diagnosis in beta-thalassemia: an Indian experience.

S Agarwal1, A Gupta, U R Gupta, S Sarwai, S Phadke, S S Agarwal.   

Abstract

OBJECTIVES: Thalassemia is the most common single gene disorder and is widely distributed in Asian Indians with an average prevalence rate of 4%, with a high prevalence among Sindhis, Punjabis, Gujratis and Bengalis. Prevention and control of beta-thalassemia disease require the accurate diagnosis of carriers and proper genetic counseling.
METHOD: Prenatal diagnosis can be performed in the first or second trimester of pregnancy by DNA analysis using polymerase chain reaction. Since there are 17 mutations as well as rare ones causing beta-thalassemia in Asian Indians, the point mutation detection by reverse dot blot (RDB) allele-specific oligonucleotide hybridization for common mutations along with the amplification refractory mutation system (ARMS) technique was developed for prenatal diagnosis. Maternal contamination of fetal DNA was ruled out by the variable number of tandem repeat analysis using apolipoprotein B site.
RESULTS: Using both techniques (RDB and ARMS) we were able to offer complete diagnosis in 53 pregnancies. On molecular analysis 23% were found to be normal, 48.0% were carriers, and 29.0% were affected with beta-thalassemia. Parents were counseled to continue the pregnancy when the fetuses were either normal or had traits whereas in the case of an affected fetus, the parents opted for termination of the pregnancy.
CONCLUSION: Prenatal diagnosis of beta-thalassemia by the RDB or ARMS technique can prevent the birth of an affected child in developing countries in which beta-thalassemia is quite prevalent. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12913343     DOI: 10.1159/000071975

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  9 in total

1.  Profiling β-thalassaemia mutations in India at state and regional levels: implications for genetic education, screening and counselling programmes.

Authors:  S Sinha; M L Black; S Agarwal; R Colah; R Das; K Ryan; M Bellgard; A H Bittles
Journal:  Hugo J       Date:  2010-02-10

2.  Sickle cell anemia--molecular diagnosis and prenatal counseling: SGPGI experience.

Authors:  Ravindra Kumar; Inusha Panigrahi; Ashwin Dalal; Sarita Agarwal
Journal:  Indian J Pediatr       Date:  2011-06-29       Impact factor: 1.967

3.  Screening for beta thalassaemia.

Authors:  Mary Petrou
Journal:  Indian J Hum Genet       Date:  2010-01

4.  Molecular genetic analyses of beta-thalassemia in South India reveals rare mutations in the beta-globin gene.

Authors:  Murali Dharan Bashyam; Leena Bashyam; Gorinabele R Savithri; Munimanda Gopikrishna; Vartul Sangal; Akela Radha Rama Devi
Journal:  J Hum Genet       Date:  2004-07-24       Impact factor: 3.172

5.  Association of polymorphic pattern of the (AT) × (T)y motif of β-globin gene in North Indian thalassemia patients with variable clinical expression.

Authors:  Vandana Arya; Sarita Agarwal; Mandakini Pradhan
Journal:  Indian J Hematol Blood Transfus       Date:  2010-08-04       Impact factor: 0.900

Review 6.  Invasive & non-invasive approaches for prenatal diagnosis of haemoglobinopathies: experiences from India.

Authors:  R B Colah; A C Gorakshakar; A H Nadkarni
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

7.  Unique pattern of mutations in β-thalassemia patients in Western Uttar Pradesh.

Authors:  Ajay F Christopher; Anita Kumari; Sunali Chaudhary; Sandhya Hora; Ziledar Ali; Satish C Agrawal
Journal:  Indian J Hum Genet       Date:  2013-04

8.  Resolution of alloimmunization and refractory autoimmune hemolytic anemia in a multi-transfused beta-thalassemia major patient.

Authors:  Joseph Philip; Neelesh Jain
Journal:  Asian J Transfus Sci       Date:  2014-07

9.  Factors associated with continuing emergence of β-thalassemia major despite prenatal testing: a cross-sectional survey.

Authors:  Haleama Al Sabbah; Sarah Khan; Abdallah Hamadna; Lamia Abu Ghazaleh; Anwar Dudin; Bashar Adnan Karmi
Journal:  Int J Womens Health       Date:  2017-09-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.